| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| Merck says key Fosamax lawsuit dismissed | | Washington Post - 9 Hours ago | | WHITEHOUSE STATION, N.J. -- Merck & Co. on Tuesday said a U.S. district court dismissed claims against the company in a second key case alleging the osteoporosis drug Fosamax causes painful jaw bone destruction. | | | | Add Comment |
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| Merck Serono Extends Chinese Footprint | | Pharmaceutical Technology - 9 Hours ago | | Merck Serono has announced plans to extend its global research and development footprint in China by investing more than â?¬150m and building an R&D centre in Beijing. The centre will lead drug development | | | | Add Comment |
|
|
|
| Positive Results for Genta's Leading Oncology Drug | | Pharmaceutical Technology - 9 Hours ago | | Genta has announced its lead oncology product Genasense shows a high response rate when administered as an intravenous infusion for the treatment of advanced melanoma. Preliminary results of a pilot study | | | | Add Comment |
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |